Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 18/20 | 0.70 |
| ▸ | PARP15 | Q460N3 | 5/20 | 0.70 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.70 |
| ▸ | PARP14 | Q460N5 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.70 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.70 |
| ▸ | PARP2 | Q9UGN5 | 4/20 | 0.64 |
| ▸ | PARP1 | P09874 | 2/20 | 0.64 |
| ▸ | CA1 | P00915 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 1/20 | 0.64 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.53 |
| ▸ | TNKS | O95271 | 1/20 | 0.52 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3137816 | 0.82 | PARP10 (1.00) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| Terephthalamide SCHEMBL23774 | 0.81 | PARP1 (0.71) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL436778 | 0.80 | CA1 (0.60) | PARP10PARP15ALDH1A1KMT2ACA1 | |
| SCHEMBL28095695 | 0.78 | PARP10 (0.67) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL17888032 | 0.78 | PARP10 (0.67) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL10915794 | 0.78 | MAPT (0.67) | ALDH1A1KMT2ACA1CA2POLB | |
| SCHEMBL15259341 | 0.78 | PARP10 (0.67) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL201761 | 0.78 | PARP10 (1.00) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL20369059 | 0.78 | PARP10 (0.67) | PARP10PARP15PARP4PARP14ALDH1A1 | |
| SCHEMBL7138100 | 0.78 | PARP10 (0.67) | PARP10PARP15PARP4PARP14ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163488-A1 | CONJUGATION METHOD INVOLVING A TRANSGLUTAMINASE AT THE FC REGION COMPRISING A TRIMMED N-GLYCAN | BLUE OWL OPPORTUNISTIC MASTER FUND I, L.P. (FORMERLY KNOWN AS OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.) | 2025-05-22 | — | — | US | disclosed |
| US-9174203-B2 | Selective and efficient bifunctional and trifunctional nanoporous catalysts and methods of synthesis thereof | PATENT INNOVATIONS LLC | 2015-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163488-A1 | CONJUGATION METHOD INVOLVING A TRANSGLUTAMINASE AT THE FC REGION COMPRISING A TRIMMED N-GLYCAN | ENGASE, B3GAT3, FCGR2A | PARP10 930/4885PARP15 511/4885PARP4 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.